<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:23:54Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7993600" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7993600</identifier>
        <datestamp>2021-04-08</datestamp>
        <setSpec>gatesmanu</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">N Engl J Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">N Engl J Med</journal-id>
              <journal-title-group>
                <journal-title>The New England Journal of Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0028-4793</issn>
              <issn pub-type="epub">1533-4406</issn>
              <publisher>
                <publisher-name>Massachusetts Medical Society</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7993600</article-id>
              <article-id pub-id-type="pmcid">PMC7993600</article-id>
              <article-id pub-id-type="pmc-uid">7993600</article-id>
              <article-id pub-id-type="pmid">33826814</article-id>
              <article-id pub-id-type="publisher-id">NEJM-2021-2023294</article-id>
              <article-id pub-id-type="doi">10.1056/NEJMoa2023294</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>A Microbiota-Directed Food Intervention for Undernourished
Children</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Robert Y.</given-names>
                  </name>
                  <degrees>B.S.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                  <xref rid="FN2" ref-type="author-notes">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mostafa</surname>
                    <given-names>Ishita</given-names>
                  </name>
                  <degrees>B.D.S., M.P.H.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                  <xref rid="FN2" ref-type="author-notes">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hibberd</surname>
                    <given-names>Matthew C.</given-names>
                  </name>
                  <degrees>Ph.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                  <xref ref-type="aff" rid="A4">4</xref>
                  <xref rid="FN2" ref-type="author-notes">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Das</surname>
                    <given-names>Subhasish</given-names>
                  </name>
                  <degrees>M.B.B.S., M.P.H.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mahfuz</surname>
                    <given-names>Mustafa</given-names>
                  </name>
                  <degrees>M.B.B.S., M.P.H.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Naila</surname>
                    <given-names>Nurun N.</given-names>
                  </name>
                  <degrees>M.B.B.S., M.P.H.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Islam</surname>
                    <given-names>Md.Munirul</given-names>
                  </name>
                  <degrees>M.B.B.S., Ph.D.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Huq</surname>
                    <given-names>Sayeeda</given-names>
                  </name>
                  <degrees>M.B.B.S., M.P.H.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alam</surname>
                    <given-names>Md.Ashraful</given-names>
                  </name>
                  <degrees>M.P.H.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zaman</surname>
                    <given-names>Mahabub Uz</given-names>
                  </name>
                  <degrees>M.P.H.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Raman</surname>
                    <given-names>Arjun S.</given-names>
                  </name>
                  <degrees>M.D., Ph.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                  <xref ref-type="aff" rid="A4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Webber</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <degrees>M.D., Ph.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                  <xref ref-type="aff" rid="A4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhou</surname>
                    <given-names>Cyrus</given-names>
                  </name>
                  <degrees>B.S.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sundaresan</surname>
                    <given-names>Vinaik</given-names>
                  </name>
                  <degrees>B.S.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ahsan</surname>
                    <given-names>Kazi</given-names>
                  </name>
                  <degrees>M.B.B.S., M.P.H.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Meier</surname>
                    <given-names>Martin F.</given-names>
                  </name>
                  <degrees>B.S.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Barratt</surname>
                    <given-names>Michael J.</given-names>
                  </name>
                  <degrees>Ph.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                  <xref ref-type="aff" rid="A4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ahmed</surname>
                    <given-names>Tahmeed</given-names>
                  </name>
                  <degrees>M.B.B.S., Ph.D.</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                  <xref rid="FN3" ref-type="author-notes">#</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gordon</surname>
                    <given-names>Jeffrey I.</given-names>
                  </name>
                  <degrees>M.D.</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A2">2</xref>
                  <xref ref-type="aff" rid="A4">4</xref>
                  <xref rid="FN3" ref-type="author-notes">#</xref>
                  <xref rid="CR1" ref-type="corresp">+</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>1</label>Edison Family Center for Genome Sciences and Systems Biology, Washington
University School of Medicine, St. Louis, MO 63110 USA </aff>
              <aff id="A2"><label>2</label>Center for Gut Microbiome and Nutrition Research, Washington University
School of Medicine, St. Louis, MO 63110 USA </aff>
              <aff id="A3"><label>3</label>International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b),
Dhaka 1212, Bangladesh </aff>
              <aff id="A4"><label>4</label>Department of Pathology and Immunology, Washington University in St. Louis
School of Medicine, St Louis, MO 63110 USA </aff>
              <author-notes>
                <fn fn-type="other" id="FN1">
                  <p id="P1">The Edison Family Center for Genome Sciences and Systems Biology (RYC, MCH,
ASR, DW, CZ, VS, KA, MM, MJB, JIG), Center for Gut Microbiome and Nutrition Research
(RYC, MCH, ASR, DW, CZ, VS, KA, MM, MJB, JIG) and Department of Pathology and Immunology
(ASR, DW, MJB, JIG), Washington University School of Medicine, St. Louis, MO 63110 USA;
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212,
Bangladesh (IM, SD, MM, NNN, Md.MI, SH, Md.AA, MUZ, TA).</p>
                </fn>
                <fn fn-type="equal" id="FN2">
                  <label>*</label>
                  <p id="P2">Contributed equally;</p>
                </fn>
                <fn fn-type="other" id="FN3">
                  <label>#</label>
                  <p id="P3">co-senior authors</p>
                </fn>
                <corresp id="CR1"><label>+</label>Address correspondence to: <email>jgordon@wustl.edu</email></corresp>
                <fn>
                  <p>This is an Author Final Manuscript, which is the version after external peer review and
before publication in the Journal. The publisher’s version of record, which
includes all New England Journal of Medicine editing and enhancements, is available at
<ext-link ext-link-type="uri" xlink:href="https://www.nejm.org/doi/full/10.1056/NEJMoa2023294">10.1056/NEJMoa2023294</ext-link>.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>7</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <day>22</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>08</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <volume>384</volume>
              <issue>16</issue>
              <fpage>1517</fpage>
              <lpage>1528</lpage>
              <permissions>
                <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This Author Accepted Manuscript is licensed for use under the CC-BY
license.</license-p>
                </license>
              </permissions>
              <abstract id="ABS1">
                <sec id="S1">
                  <title>BACKGROUND</title>
                  <p id="P4">More than 30 million children worldwide suffer from moderate acute malnutrition
(MAM). Current treatments have limited effectiveness and much remains unknown about
pathogenesis. Children with MAM exhibit perturbed development of their gut
microbiota.</p>
                </sec>
                <sec id="S2">
                  <title>METHODS</title>
                  <p id="P5">Slum-dwelling Bangladeshi children, aged 12 to 18 months, with moderate acute
malnutrition (n=124) received a microbiota-directed complementary food (MDCF-2) or an
existing ready-to-use supplementary food (RUSF), twice daily for three months followed
by a 1-month period of monitoring. We obtained weight-for-length, weight-for-age, and
length-for-age Z-scores and mid-upper arm circumference at baseline and fortnightly,
through four months. We compared the rate of change of these related phenotypes between
baseline and three months, and between baseline and four months. We also measured levels
of 4,977 proteins in plasma plus 209 bacterial taxa in fecal samples.</p>
                </sec>
                <sec id="S3">
                  <title>RESULTS</title>
                  <p id="P6">118 children completed the intervention (n=59/arm). The rate of change in
weight-for-length Z-score (β-WLZ), weight-for-age Z-score, and mid upper arm
circumference is consistent with a benefit of MDCF-2 on growth over the course of the
study including the one-month follow-up. Receipt of MDCF-2 was linked to the magnitude
of change in levels of 70 β-WLZ-positively correlated plasma proteins including
mediators of bone growth, neurodevelopment and inflammation (gene set enrichment
analysis [GSEA];p&lt;0.001) and the abundances of 23 WLZ-associated bacterial taxa
(GSEA;p&lt;0.001).</p>
                </sec>
                <sec id="S4">
                  <title>CONCLUSIONS</title>
                  <p id="P7">These findings provide support for further clinical investigation of MDCF-2 as
a dietary supplement for young children with MAM and provide insight into mechanisms by
which this targeted manipulation of microbiota components may be linked to growth.
(Supported by the Bill and Melinda Gates Foundation and the NIH; <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> identifier:<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04015999">NCT04015999</ext-link>)</p>
                </sec>
              </abstract>
            </article-meta>
          </front>
          <body>
            <p id="P8">Childhood undernutrition is a global health challenge that produces impaired ponderal
and linear growth (wasting and stunting), immune and metabolic dysfunction, altered central
nervous system (CNS) development as well as other abnormalities(<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>). Acute malnutrition in children is
classified by their degree of wasting: e.g., moderate acute malnutrition (MAM) and severe
acute malnutrition (SAM) are defined by a weight-for-length Z score (WLZ) that is 2–3
or &gt;3 standard deviations, respectively, below the median of a WHO Multicentre Growth
Reference Study cohort(<xref rid="R3" ref-type="bibr">3</xref>). Children with MAM and SAM
have defects in the development of their gut microbiota, leaving them with microbial
communities that appear younger than those of their healthy counterparts(<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref>). Current nutritional
interventions for MAM and SAM have not focused on the microbiota as a therapeutic target.
Coincidentally, existing therapies have limited efficacy in treating the long-term sequelae
that affect undernourished children(<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>) and in repairing their microbiota(<xref rid="R8" ref-type="bibr">8</xref>). With the COVID-19 pandemic estimated to increase childhood deaths from wasting
by more than 20%(<xref rid="R9" ref-type="bibr">9</xref>), surmounting this already formidable
global health challenge has become even more pressing.</p>
            <p id="P9">We previously identified a network (‘ecogroup’) of 15 bacterial taxa
whose covarying representation describes normal gut microbial community development during the
first 2 years of postnatal life in healthy members of birth cohorts from several low- and
middle-income countries(<xref rid="R5" ref-type="bibr">5</xref>). Changes in the abundances of
ecogroup taxa provide a way of defining the severity of microbiota perturbations in children
with untreated MAM and SAM, as well as characterizing the incomplete nature of microbiota
repair that occurs when they receive existing therapeutic foods(<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R8" ref-type="bibr">8</xref>). Comparisons of gnotobiotic mice
colonized with fecal microbiota from age-matched healthy children or those with
wasting/stunting have revealed bacteria discriminatory for weight gain, a number of which are
ecogroup taxa(<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R10" ref-type="bibr">10</xref>). Supplementing mice harboring microbiota from a wasted/stunted child with five
of these strains prevented microbiota-dependent transmission of an impaired weight-gain
phenotype(<xref rid="R10" ref-type="bibr">10</xref>). Based on these observations, and
through screening combinations of food staples in gnotobiotic mice and gnotobiotic piglets, we
developed several microbiota-directed complementary food (MDCF) prototypes(<xref rid="R8" ref-type="bibr">8</xref>). Three of these formulations were compared to an existing
ready-to-use supplementary food (RUSF) in a 1-month-long, randomized controlled trial of
12–18-month-old children with MAM living in an urban slum in the Mirpur district of
Dhaka, Bangladesh. One of these formulations (‘MDCF-2’) changed the microbiota
to a composition similar to that of aged-matched healthy Mirpur children and changed the
abundances of plasma proteins indicative of improved health status(<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R8" ref-type="bibr">8</xref>). We have now performed a
larger, longer study to compare the effects of MDCF-2 and RUSF on clinical endpoints.</p>
            <sec id="S5">
              <title>METHODS</title>
              <sec id="S6">
                <title>Study design</title>
                <p id="P10">This study was approved by the Ethical Review Committee at the icddr,b and
conducted in Mirpur between November 2018 and December 2019. Parents/guardians of all
study participants provided written informed consent.</p>
                <p id="P11">Male and female children with MAM between 12- and 18-months-old who satisfied
the inclusion/exclusion criteria (n=124) were randomized to receive MDCF-2 or RUSF (see
Table S1 for compositions and nutritional analysis, Supplementary Methods for inclusion
criteria and sample size calculation, and <xref rid="F1" ref-type="fig">Figure 1A</xref>
for study design and data/biospecimen collection schedules). The caloric density of MDCF-2
is lower than RUSF (204 versus 247 kcal/50 g daily dose, Table S1). Anthropometry was
measured every 15 days while morbidity data were documented daily. Field Research
Assistants monitored participants for any side effects/adverse events and treated them
according to standard-of-care, if needed.</p>
                <p id="P12">During the first month, two daily 25g servings of MDCF-2 or RUSF were provided
to each child by her/his mother at a local study center under the supervision of a
health-care provider; the amount unconsumed was determined by weighing. In the second
month, one of the two daily feedings, and in the third month both daily feedings occurred
at home under the supervision of a visiting health-care provider, with documentation of
the amount consumed. Other than being asked to avoid feeding their children during the
2-hour period before each visit, mothers were advised to continue their usual
breastfeeding and complementary feeding practices throughout the study. After completing
three months of intervention, children returned to their normal feeding routine but
continued to be monitored, with fecal samples and anthropometric data collected 1-month
post-treatment.</p>
              </sec>
              <sec id="S7">
                <title>End points</title>
                <p id="P13">Outcome measures were the weekly rate of change in weight-for-length z-score
(WLZ), weight-for-age z-score (WAZ), mid-upper-arm circumference (MUAC), length-for-age
z-score (LAZ), morbidity, plasma proteomic profile, and gut microbiota configuration.</p>
              </sec>
              <sec id="S8">
                <title>Statistical analysis</title>
                <p id="P14">Changes in ponderal growth between treatment arms were compared using linear
mixed-effects models that included a random-effect coefficient to control for differences
in characteristics between individuals; other anthropometric measures were assessed in a
similar fashion. Analyses of food-frequency questionnaire and morbidity data were
performed using generalized linear mixed-effects models. Because we tested the effects of
the supplements on four measures of growth and did not correct for multiple testing, we
have provided confidence intervals for each outcome.</p>
                <p id="P15">Changes in plasma protein abundances were analyzed using an Empirical Bayes
linear model framework [limma(<xref rid="R12" ref-type="bibr">12</xref>)] and gene set
enrichment analysis [GSEA(<xref rid="R13" ref-type="bibr">13</xref>)], a method for
quantifying whether a rank-ordered list of features (e.g., proteins ranked by their
changes in abundances after a treatment or by correlation coefficient) are enriched for a
subset of features of interest (e.g., a biological pathway). Effects of supplementation on
microbial community configuration were quantified using linear mixed-effects models and
GSEA. For all statistical analyses, p&lt;0.05 was considered as ‘statistically
significant’. For analyses requiring adjustment for multiple hypotheses, those that
reached a false discovery-rate (FDR) adjusted p-value (q-value) &lt;0.1 or
≤0.05 for plasma proteomic and fecal microbial datasets, respectively, were deemed
statistically significant. All reported p-values are two-sided.</p>
              </sec>
            </sec>
            <sec id="S9">
              <title>RESULTS</title>
              <sec id="S10">
                <title>Clinical characteristics and response to nutritional intervention</title>
                <p id="P16">Children with MAM, 15.4±2.0 (mean±SD) months-of-age, living in
Mirpur were enrolled in a 3-month randomized study of twice-daily dietary supplementation
with either MDCF-2 (n=61) or RUSF (n=62) (Figure S1). Fifty-nine children in each arm
completed the 3-month intervention and 1-month follow-up. Five did not complete the study,
due to the family moving or withdrawal of consent (Figure S1).</p>
                <p id="P17">At enrollment, anthropometric and socio-demographic characteristics did not
differ between children in the two arms (<xref rid="T1" ref-type="table">Table 1</xref>,
<xref rid="T2" ref-type="table">Table 2</xref>, Table S3). Over the 3-month intervention
period, there was no difference in the amount of supplement consumed between children
receiving MDCF-2 or RUSF [92.5±0.73% (mean±SEM) of the amount provided
versus 92±1.15%, respectively; p=0.87]. There were no discernible differences in
the proportion of children meeting WHO requirements for minimum meal frequency or minimum
acceptable diet (Supplementary Results, see Table S4 for dietary practices).</p>
                <p id="P18">A mixed effects linear model predicting anthropometry as a function of the
interaction between treatment group and weeks since starting nutritional supplementation
(controlling for the main effects of baseline age, gender, illness 7 days prior to
starting the intervention, weeks in the intervention, treatment group, and a random
intercept for each participant) yielded β-indices of 0.011 (CI, 0.001, 0.021) for
WLZ, 0.008 (0.001, 0.015) for WAZ, 0.003 (CI, −0.001 , 0.007) for MUAC, and
−0.001 (CI, −0.005, 0.003) for LAZ (<xref rid="T2" ref-type="table">Table
2</xref>) (A positive value indicates a faster growth rate in children receiving MDCF-2
compared to RUSF. For example, extrapolating a β-WLZ of +0.011 over a year period
would equate to a gain of 0.57 WLZ compared to RUSF). β-indices for the 4-month
period encompassing the 3-month intervention and 1-month follow-up were 0.010 (0.002,
0.018) for WLZ, 0.008 (0.002, 0.013) for WAZ, 0.004 (0.000, 0.007) for MUAC, and 0.000
(−0.003, 0.003) for LAZ (<xref rid="F1" ref-type="fig">Figure 1B</xref>, <xref rid="T2" ref-type="table">Table 2</xref>, Table S5). See Figures S2, S3, Table S4 and
Table S6) for effects on morbidity and dietary habits.</p>
              </sec>
              <sec id="S11">
                <title>Effects of Intervention on Plasma Proteome</title>
                <p id="P19">We quantified the abundances of 4,977 proteins(<xref rid="R14" ref-type="bibr">14</xref>) in plasma samples collected from all 118 children in the study at the 0-, 1-
and 3-month time points (Table S2, Figure S4A,B). For each child, a linear model relating
the duration of supplementation to his/her β-WLZ during the 3-month intervention
was constructed; β-WLZ was then correlated with changes in the abundances of plasma
proteins prior to and after completing the intervention (Δprotein abundance, <xref rid="F2" ref-type="fig">Figure 2A</xref>–<xref rid="F2" ref-type="fig">C</xref>).
Seventy-five proteins were identified as significantly correlated (positively or
negatively) with β-WLZ [false discovery rate (FDR)-adjusted q&lt;0.1, Table
S7]. Gene set enrichment analysis (GSEA) querying Gene Ontology (GO) ‘biological
processes’ revealed that proteins positively correlated with β-WLZ were
significantly enriched (q&lt;0.1) for (i) mediators of bone growth and ossification
[e.g., insulin-like growth factor 1 (IGF1); cartilage oligomeric matrix protein (COMP, an
extracellular matrix protein critical for endochondral bone growth;<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>); secreted
frizzled-related protein 4 (SFRP4, Wnt inhibitor that prevents excessive osteoclast
erosion of bone;<xref rid="R17" ref-type="bibr">17</xref>) (<xref rid="F2" ref-type="fig">Figure 2D</xref>,<xref rid="F2" ref-type="fig">E</xref>; Table S7,S8)] and (ii) CNS
development [e.g., the axon guidance protein SLIT and NTRK-like protein 5 (SLITRK5);
BDNF/NT-3 growth factor receptor (NTRK3) and roundabout homolog 2 (ROBO2, axon guidance
receptor with pro-osteoblastic/anti-osteoclastic activities;<xref rid="R18" ref-type="bibr">18</xref>) (<xref rid="F2" ref-type="fig">Figure 2F</xref>, Table
S7,S8)]. Proteins whose abundances negatively correlated with ponderal growth were
significantly enriched for acute phase reactants and actuators of immune activation [e.g.,
hepcidin (HAMP; reduces iron absorption and induces iron sequestration during inflammatory
states); RANKL (osteoclast-promoting factor); granulysin (GNLY, proinflammatory cytokine
produced by activated cytotoxic T- and NK-cells); interferon-induced protein with
tetratricopeptide repeat-3 (IFIT3, inhibits the replication of multiple viral
pathogens(<xref rid="R19" ref-type="bibr">19</xref>)); and immunoglobulin A (IGHA1)
(<xref rid="F2" ref-type="fig">Figure 2G</xref>,<xref rid="F2" ref-type="fig">H</xref>,
Table S7,S8)].</p>
                <p id="P20">A total of 714 proteins exhibited significantly (q&lt;0.1) higher or lower
levels after the 3-month MDCF-2 supplementation, in contrast with 82 proteins that showed
significant alterations after RUSF treatment (Table S9A,B). Proteins that showed increases
after 3 months of supplementation with MDCF-2 were significantly enriched for the 70
positively β-WLZ-associated proteins (GSEA p&lt;0.001), in contrast with the
proteins that showed increases after RUSF supplementation (GSEA p=0.11, Figure S5A,B).
Comparing the two treatments revealed that proteins whose levels increased more with
MDCF-2 were significantly enriched for WLZ-associated proteins (GSEA p&lt;0.001, <xref rid="F2" ref-type="fig">Figure 2I</xref>). Of the WLZ-associated proteins elevated after
MDCF-2 supplementation, cartilage intermediate layer protein 2 (CILP2) was elevated to the
greatest extent. Its levels did not change in children who received RUSF. It forms
complexes with collagen VI to promote articular cartilage formation and regulates
metabolic status(<xref rid="R20" ref-type="bibr">20</xref>). Other proteins significantly
increased by MDCF-2 but not RUSF included thrombospondin-4 (THBS4), a multifunctional
protein involved in bone, skeletal muscle, vascular, and nervous system development(<xref rid="R21" ref-type="bibr">21</xref>), and the osteoclast inhibitor SFRP4.</p>
                <p id="P21">Analysis of the plasma proteomes of children given MDCF-2 by quartile of
ponderal growth rate (β-WLZ) (n=15 children/group) revealed that those in the upper
quartile started off more wasted, were more deplete of mediators of bone growth and
neurodevelopment and had higher levels of pro-inflammatory proteins compared to those in
the lower quartile. By the end of MDCF-2 supplementation, children in the upper quartile
manifested the largest increases in mediators of bone growth and CNS development and the
largest decreases in effectors of inflammation (Figure S6A,B, Tables S10,S11;
Supplementary Results). Together, these results provide evidence that mediators of bone
growth, neurodevelopment and inflammation distinguish the effects of the
microbiota-directed nutritional intervention from that of RUSF.</p>
              </sec>
              <sec id="S12">
                <title>Effects of Supplementation on Gut Microbiota</title>
                <p id="P22">To determine the effects of supplementation on gut microbiota, fecal samples
were obtained every 10 days during the first month of the intervention and monthly
thereafter. Quantitative PCR assays revealed no statistically significant differences
between treatments in the representation of 23 bacterial, viral and protozoan
enteropathogens (Table S12). A more comprehensive analysis was obtained by identifying
bacterial taxa through sequencing of PCR amplicons generated from variable region 4 of 16S
rDNA genes present in fecal biospecimens (Figure S7). We then used linear mixed-effects
models to determine the relationships between the abundances of bacterial taxa [defined by
the representation of amplicon sequence variants (ASVs); see Supplementary Methods] and
WLZ in each participant.</p>
                <p id="P23">Analyzing ASV data generated from 706 fecal samples with temporally-matched
anthropometry from all participants revealed that among the 209 ASVs that satisfied our
threshold for prevalence and abundance, 23 were significantly correlated with WLZ
(‘WLZ-associated’ taxa); 21 were positively associated while two were
negatively associated (<italic>Bifidobacterium</italic> sp. (ASV_1, likely <italic>B.
longum</italic>) and <italic>Escherichia coli</italic> (ASV_3) (<xref rid="F3" ref-type="fig">Figure 3A</xref>, Table S13). Six of the WLZ-associated taxa (bolded ASVs
in <xref rid="F3" ref-type="fig">Figure 3A</xref>) are members of the ecogroup network of
bacteria whose representation describes normal gut microbial community development in
healthy Bangladeshi infants/children(<xref rid="R5" ref-type="bibr">5</xref>). In this
previous study, microbiota repair by MDCF-2 was accompanied by changes in two of these six
WLZ-correlated ecogroup taxa: increases in <italic>Prevotella copri</italic> and
reductions in <italic>Bifidobacterium longum</italic>(<xref rid="R5" ref-type="bibr">5</xref>). Five of the WLZ-associated ASVs identified in the present study (asterisks
in <xref rid="F3" ref-type="fig">Figure 3A</xref>) share taxonomic similarity with
bacteria identified as discriminatory for weight gain in our previous studies of
gnotobiotic mice colonized with fecal microbiota from healthy versus malnourished
children; they include <italic>Faecalibacterium prausnitzii</italic>, <italic>Dorea
formicigenerans</italic>, <italic>Ruminococcus gnavus</italic> and a member of
<italic>Clostridium.</italic> Importantly, the complementary food ingredients
incorporated into MDCF-2 were selected based on their abilities to increase the fitness
and expressed beneficial functions of these age- and growth-discriminatory taxa(<xref rid="R8" ref-type="bibr">8</xref>). An analysis of covariance between features of the
plasma proteome and members of the gut microbiota revealed that the abundances of these 21
WLZ-positively associated taxa were associated with the 70 plasma proteins whose levels
positively correlated with β-WLZ (Figures S8–S10; Tables S14, S15;
Supplementary Results). See Supplementary Results and Table S16 for analyses of bacterial
taxa associations with dietary practices.</p>
                <p id="P24">The abundances of WLZ-associated taxa were significantly greater in the gut
microbiota of children whose diets were supplemented by MDCF-2 than in those of children
whose diets were supplemented by RUSF (p&lt;0.001, GSEA; <xref rid="F3" ref-type="fig">Figure 3B</xref>). Figure S11 and Table S17 rank WLZ-associated taxa based on the
magnitude of their changes in relative abundances during MDCF-2 treatment; the greatest
increases occurred with <italic>P. copri</italic> and <italic>F. prausnitzii,</italic>
while the <italic>Bifidobacterium</italic> sp. (likely <italic>B. longum</italic>)
exhibited the greatest decrease. Additionally, compared to (unsupplemented) children from
Mirpur with consistently healthy growth phenotypes (WLZ ≥−1) and normally
developing microbiota, MDCF-2 produced a significant enhancement in the rate of change in
abundances of ASVs assigned to members of <italic>Prevotella</italic> (including
<italic>P. copri</italic>), <italic>F. prausnitzii</italic>, <italic>Olsenella</italic>,
and <italic>Bifidobacterium</italic> (<italic>B. longum</italic>) – i.e. those
among the most highly positively and negatively correlated with WLZ. In contrast, RUSF did
not elicit significant differences in the rate of change in abundance of any of the 23
WLZ-correlated ASVs (Figure S12, Table S18, S19). One month after cessation of
supplementation, levels of a majority of MDCF-2-responsive, WLZ-associated ASVs had begun
to fall at the same time that WLZ was diminishing (Figure S13A–D).</p>
              </sec>
            </sec>
            <sec id="S13">
              <title>DISCUSSION</title>
              <p id="P25">We describe the results of a randomized, controlled feeding study testing the
effects of a microbiota-directed complementary food (MDCF-2) against an existing
supplementary food (RUSF) on four measures of growth in 12–18-month-old Bangladeshi
children with MAM. The rate of changes we observed in WLZ score, WAZ score and MUAC, but not
LAZ score, support a benefit of MDCF-2 on growth despite its lower caloric density compared
to RUSF. We observed larger changes in plasma protein mediators of bone growth,
neurodevelopment and inflammation and more complete repair of the gut microbiota of children
who received MDCF-2 compared with those who received RUSF.</p>
              <p id="P26">We did not attempt to test the effects of MDCF-2 and RUSF on body composition
(changes in fat-versus lean-mass). Chronic undernutrition in early life induces metabolic
reprogramming that may enable a child to more efficiently capture and store energy as fat
during periods of nutrient scarcity(<xref rid="R22" ref-type="bibr">22</xref>). While
adaptive in the short-term, this metabolic shift predisposes children to developing
diabetes, hypertension, and cardiovascular disease later in life(<xref rid="R23" ref-type="bibr">23</xref>). MDCF-2 elicits a concerted change in WLZ-associated proteins,
a number of which are effectors of bone growth and skeletal muscle development. Some of
these proteins have also been implicated in metabolic disorders(<xref rid="R24" ref-type="bibr">24</xref>–<xref rid="R30" ref-type="bibr">30</xref>). However,
augmenting growth of bone and skeletal muscle may promote a rebalancing of the rapid
‘catch-up’ fat accretion, observed when undernourished children are given
standard nutritional interventions, towards a more appropriate lean-to-fat mass ratio,
simultaneously improving growth and protecting from later obesity(<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref>).</p>
              <p id="P27">Studies conducted in children with MAM in Malawi and Ethiopia indicate that
increases in ‘fat-free’ mass accretion in the first two years of life are
associated with better cognitive and motor development(<xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref>). Children who received MDCF-2
exhibited increased plasma levels of proteins associated with axonal growth and CNS
development, but whether this observation has anything to do with changes in the central
nervous system is not known. It will be important to follow cohorts of children with MAM
treated with MDCF-2 for longer periods of time to assess whether the observed changes in
these proteins correlate with clinical improvements in cognitive performance.</p>
              <p id="P28">A hallmark of a successfully executed program of gut community development in
Bangladeshi children (and those in other resource-poor settings) is the transition from a
<italic>Bifidobacterium longum</italic>-dominated community during exclusive/predominant
breastfeeding, to one in which <italic>Prevotella copri</italic> becomes a major component
during weaning(<xref rid="R5" ref-type="bibr">5</xref>). While <italic>B. longum</italic>
has been associated with numerous beneficial outcomes in breast-feeding infants, its
abundance was negatively associated with ponderal growth rate in the 12–18-month-old
children enrolled in the present study, which underscores the importance of considering how
the timing of nutritional intervention aligns with the state of microbiota development.</p>
              <p id="P29">Larger trials performed in disparate geographies are needed to further assess the
efficacy of this therapeutic approach for treating childhood undernutrition. The plasma and
microbiota biomarkers identified in the present study should help enable better
characterization (and stratification) of participants in future interventions.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="SUPP1">
                <media xlink:href="NEJMoa-2021-2023294-s1.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="SUPP2">
                <media xlink:href="NEJMoa-2021-2023294-s2.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="S14">
              <title>ACKNOWLEDGEMENTS</title>
              <p id="P31">We are indebted to the families of study participants for their assistance. We are
grateful to the investigators and staff at icddr,b for their contributions to the
recruitment and enrollment of participants and the collection of biospecimens and clinical
metadata. We thank Su Deng and J. Hoisington-López for superb technical assistance
and Chris Sawyer (Genome Technology Access Center at Washington University) for generating
qPCR datasets. We are grateful to SomaLogic for providing access to their v4 5k SomaScan
platform, and Josh Lovato and Darryl Perry for their assistance in generating proteomic
datasets and providing technical guidance on data normalization.</p>
              <p id="P32">SUPPORT</p>
              <p id="P33">This work was supported by the Bill &amp; Melinda Gates Foundation and the NIH
(DK30292). R.Y.C. is the recipient of a dual degree training award from the NIH
(F30DK124967) and a member of the Medical Scientist Training Program at Washington
University, which is supported by NIH grant GM007200. A.S.R. and D.W. are members of the
Washington University School of Medicine Physician Scientist Training Program. J.I.G. is the
recipient of a Thought Leader award from Agilent Technologies.</p>
            </ack>
            <fn-group>
              <fn id="FN4">
                <p id="P30">Disclosure forms provided by the authors are available with the full text of
this article at <ext-link ext-link-type="uri" xlink:href="http://NEJM.org">NEJM.org</ext-link>.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>REFERENCES</title>
              <ref id="R1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><name><surname>Black</surname><given-names>R.E.</given-names></name>, <name><surname>Allen</surname><given-names>L.H.</given-names></name>, <name><surname>Bhutta</surname><given-names>Z.A.</given-names></name>, <name><surname>Caufield</surname><given-names>L.E.</given-names></name>, <name><surname>de Onis</surname><given-names>M.</given-names></name>, <name><surname>Ezzati</surname><given-names>M.</given-names></name>, <name><surname>Mathers</surname><given-names>C.</given-names></name>, <name><surname>Rivera Maternal</surname><given-names>J.</given-names></name> and <article-title>child undernutrition: global and regional exposures and health
consequences</article-title>. <source>Lancet</source>. <volume>371</volume>,
<fpage>243</fpage>–<lpage>260</lpage> (<year>2008</year>). <pub-id pub-id-type="pmid">18207566</pub-id></mixed-citation>
              </ref>
              <ref id="R2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><name><surname>Black</surname><given-names>R.E.</given-names></name>, <name><surname>Victora</surname><given-names>C.G.</given-names></name>, <name><surname>Walker</surname><given-names>S.P.</given-names></name>, <name><surname>Bhutta</surname><given-names>Z.A.</given-names></name>, <name><surname>Christian</surname><given-names>P.</given-names></name>, <name><surname>de Onis</surname><given-names>M.</given-names></name>, <name><surname>Ezzati</surname><given-names>M.</given-names></name>, <name><surname>Grantham-McGregor</surname><given-names>S.</given-names></name>, <name><surname>Katz</surname><given-names>J.</given-names></name>, <name><surname>Martorell</surname><given-names>R.</given-names></name>, <name><surname>Uauy</surname><given-names>R.</given-names></name>. <article-title>Maternal and child undernutrition and overweight in low-income and
middle-income countries</article-title>. <source>Lancet</source>. <volume>382</volume>,
<fpage>427</fpage>‐<lpage>451</lpage> (<year>2013</year>). <pub-id pub-id-type="pmid">23746772</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3.</label>
                <mixed-citation publication-type="book"><collab>WHO Multicentre Growth Reference Study Group</collab>. <source>WHO Child Growth
Standards: Growth velocity based on weight, length and head circumference: Methods and
development</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World
Health Organization</publisher-name> (<year>2009</year>). </mixed-citation>
              </ref>
              <ref id="R4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><name><surname>Subramanian</surname><given-names>S.</given-names></name>, <name><surname>Huq</surname><given-names>S.</given-names></name>, <name><surname>Yatsunenko</surname><given-names>T.</given-names></name>, <name><surname>Haque</surname><given-names>R.</given-names></name>, <name><surname>Mahfuz</surname><given-names>M.</given-names></name>, <name><surname>Alam</surname><given-names>M.A.</given-names></name>, <name><surname>Benezra</surname><given-names>A.</given-names></name>, <name><surname>Destefano</surname><given-names>J.</given-names></name>, <name><surname>Meier</surname><given-names>M.F.</given-names></name>, <name><surname>Muegge</surname><given-names>B.D.</given-names></name>, <name><surname>Barratt</surname><given-names>M.J.</given-names></name>, <name><surname>VanArendonk</surname><given-names>L.G.</given-names></name>, <name><surname>Zhang</surname><given-names>Q.</given-names></name>, <name><surname>Province</surname><given-names>M.A.</given-names></name>, <name><surname>Petri</surname><given-names>W.A.</given-names></name>, <name><surname>Ahmed</surname><given-names>T.</given-names></name>, <name><surname>Gordon</surname><given-names>J.I.</given-names></name>. <article-title>Persistent gut microbiota immaturity in malnourished Bangladeshi
children</article-title>. <source>Nature</source><volume>510</volume>, <fpage>417</fpage>–<lpage>421</lpage> (<year>2014</year>).
<pub-id pub-id-type="pmid">24896187</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><name><surname>Raman</surname><given-names>A.S.</given-names></name>, <name><surname>Gehrig</surname><given-names>J.L.</given-names></name>, <name><surname>Venkatesh</surname><given-names>S</given-names></name>, <name><surname>Chang</surname><given-names>H.W.</given-names></name>, <name><surname>Hibberd</surname><given-names>M.C.</given-names></name>, <name><surname>Subramanian</surname><given-names>S.</given-names></name>, <name><surname>Kang</surname><given-names>G.</given-names></name>, <name><surname>Bessong</surname><given-names>P.O.</given-names></name>, <name><surname>Lima</surname><given-names>A.A.M.</given-names></name>, <name><surname>Kosek</surname><given-names>M.N.</given-names></name>,<name><surname>Petri</surname><given-names>W.A.</given-names></name>, <name><surname>Rodionov</surname><given-names>D.A.</given-names></name>, <name><surname>Arzamasov</surname><given-names>A.A.</given-names></name>, <name><surname>Leyn</surname><given-names>S.A.</given-names></name>, <name><surname>Osterman</surname><given-names>A.L.</given-names></name>, <name><surname>Huq</surname><given-names>S.</given-names></name>, <name><surname>Mostafa</surname><given-names>I</given-names></name>, <name><surname>Islam</surname><given-names>M.</given-names></name>, <name><surname>Mahfuz</surname><given-names>M.</given-names></name>, <name><surname>Haque</surname><given-names>R.</given-names></name>, <name><surname>Ahmed</surname><given-names>T.</given-names></name>, <name><surname>Barratt</surname><given-names>M.J.</given-names></name>, <name><surname>Gordon</surname><given-names>J.I.</given-names></name>. <article-title>A sparse covarying unit that describes healthy and impaired human
gut microbiota development</article-title>. <source>Science</source><volume>365</volume>, <fpage>eaau4735</fpage> (<year>2019</year>). <pub-id pub-id-type="pmid">31296739</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><name><surname>Dewey</surname><given-names>K.G.</given-names></name>. <article-title>Reducing stunting by improving maternal, infant and young child
nutrition in regions such as South Asia: evidence, challenges and
opportunities</article-title>. <source>Matern Child Nutr</source>. <volume>12</volume>,
(<issue>Suppl 1</issue>) <fpage>27</fpage>‐<lpage>38</lpage> (<year>2016</year>).
<pub-id pub-id-type="pmid">27187908</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><name><surname>Goudet</surname><given-names>S.M.</given-names></name>, <name><surname>Bogin</surname><given-names>B.A.</given-names></name>, <name><surname>Madise</surname><given-names>N.J.</given-names></name>, <name><surname>Griffiths</surname><given-names>P.L.</given-names></name>. <article-title>Nutritional interventions for preventing stunting in children
(birth to 59 months) living in urban slums in low- and middle-income countries
(LMIC)</article-title>. <source>Cochrane Database of Systematic Reviews</source>,
<volume>6</volume>, <comment>Art. No.</comment><fpage>CD011695</fpage> (<year>2019</year>). </mixed-citation>
              </ref>
              <ref id="R8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><name><surname>Gehrig</surname><given-names>J.L.</given-names></name>, <name><surname>Venkatesh</surname><given-names>S.</given-names></name>, <name><surname>Chang</surname><given-names>H.W.</given-names></name>, <name><surname>Hibberd</surname><given-names>M.C.</given-names></name>, <name><surname>Kung</surname><given-names>V.L.</given-names></name>, <name><surname>Cheng</surname><given-names>J.</given-names></name>, <name><surname>Chen</surname><given-names>R.Y.</given-names></name>, <name><surname>Subramanian</surname><given-names>S.</given-names></name>, <name><surname>Cowardin</surname><given-names>C.A.</given-names></name>, <name><surname>Meier</surname><given-names>M.</given-names></name>, <name><surname>O’Donnell</surname><given-names>D.</given-names></name>, <name><surname>Talcott</surname><given-names>M.</given-names></name>, <name><surname>Spears</surname><given-names>L.D.</given-names></name>, <name><surname>Semenkovich</surname><given-names>C.C.</given-names></name>, <name><surname>Henrissat</surname><given-names>B.</given-names></name>, <name><surname>Giannone</surname><given-names>R.J.</given-names></name>, <name><surname>Hettich</surname><given-names>R.L.</given-names></name>, <name><surname>Ilkayeva</surname><given-names>O.</given-names></name>, <name><surname>Muehlbauer</surname><given-names>M.</given-names></name>, <name><surname>Newgard</surname><given-names>C.B.</given-names></name>, <name><surname>Sawyer</surname><given-names>C.</given-names></name>, <name><surname>Head</surname><given-names>R.D.</given-names></name>, <name><surname>Rodionov</surname><given-names>D.A.</given-names></name>, <name><surname>Arzamasov</surname><given-names>A.A.</given-names></name>, <name><surname>Leyn</surname><given-names>S.A.</given-names></name>, <name><surname>Osterman</surname><given-names>A.L.</given-names></name>, <name><surname>Hossain</surname><given-names>Md I.</given-names></name>, <name><surname>Islam</surname><given-names>M.</given-names></name>, <name><surname>Choudhury</surname><given-names>N.</given-names></name>, <name><surname>Sarker</surname><given-names>S.A.</given-names></name>, <name><surname>Huq</surname><given-names>S.</given-names></name>, <name><surname>Mahnud</surname><given-names>I.</given-names></name>, <name><surname>Mostafa</surname><given-names>I.</given-names></name>, <name><surname>Mahfuz</surname><given-names>M.</given-names></name>, <name><surname>Barratt</surname><given-names>M.J.</given-names></name>, <name><surname>Ahmed</surname><given-names>T.</given-names></name>, <name><surname>Gordon</surname><given-names>J.I.</given-names></name>. <article-title>Effects of microbiota-directed foods in gnotobiotic animals and
undernourished children</article-title>. <source>Science</source><volume>365</volume>, <fpage>eaau4732</fpage> (<year>2019</year>). <pub-id pub-id-type="pmid">31296738</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><name><surname>Roberton</surname><given-names>T.</given-names></name>, <name><surname>Carter</surname><given-names>E.D.</given-names></name>, <name><surname>Chou</surname><given-names>V.B.</given-names></name>, <name><surname>Stegmuller</surname><given-names>A.R.</given-names></name>, <name><surname>Jackson</surname><given-names>B.D.</given-names></name>, <name><surname>Tam</surname><given-names>Y.</given-names></name><etal/><article-title>Early estimates of the indirect effects of the COVID-19 pandemic on
maternal and child mortality in low-income and middle-income countries: a modelling
study</article-title>. <source>Lancet Global Health</source> DOI:<pub-id pub-id-type="doi">10.1016/S2214-109X(20)30229-1</pub-id> (<year>2020</year>). </mixed-citation>
              </ref>
              <ref id="R10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><name><surname>Blanton</surname><given-names>L.V.</given-names></name>, <name><surname>Charbonneau</surname><given-names>M.R.</given-names></name>, <name><surname>Salih</surname><given-names>T.</given-names></name>, <name><surname>Barratt</surname><given-names>M.J.</given-names></name>, <name><surname>Venkatesh</surname><given-names>S.</given-names></name>, <name><surname>Ilkaveya</surname><given-names>O.</given-names></name>, <name><surname>Subramanian</surname><given-names>S.</given-names></name>, <name><surname>Manary</surname><given-names>M.J.</given-names></name>, <name><surname>Trehan</surname><given-names>I.</given-names></name>, <name><surname>Jorgensen</surname><given-names>J.M.</given-names></name>, <name><surname>Fan</surname><given-names>Y.M.</given-names></name>, <name><surname>Henrissat</surname><given-names>B.</given-names></name>, <name><surname>Leyn</surname><given-names>S.A.</given-names></name>, <name><surname>Rodionov</surname><given-names>D.A.</given-names></name>, <name><surname>Osterman</surname><given-names>A.L.</given-names></name>, <name><surname>Maleta</surname><given-names>K.M.</given-names></name>, <name><surname>Newgard</surname><given-names>C.B.</given-names></name>, <name><surname>Ashorn</surname><given-names>P.</given-names></name>. <name><surname>Dewey</surname><given-names>K.G.</given-names></name>, <name><surname>Gordon</surname><given-names>J.I.</given-names></name>. <article-title>Gut bacteria that prevent growth impairments transmitted by
microbiota from malnourished children</article-title>. <source>Science</source><volume>351</volume>, <fpage>aad3311</fpage> (<year>2016</year>) <pub-id pub-id-type="pmid">26912898</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><name><surname>Mostafa</surname><given-names>I.</given-names></name>, <name><surname>Nahar</surname><given-names>N.N.</given-names></name>, <name><surname>Islam</surname><given-names>Md.M.</given-names></name>, <name><surname>Huq</surname><given-names>S.</given-names></name>, <name><surname>Mustafa</surname><given-names>M.</given-names></name>, <name><surname>Barratt</surname><given-names>M.J.</given-names></name>, <name><surname>Gordon</surname><given-names>J.I.</given-names></name>, <name><surname>Ahmed</surname><given-names>T.</given-names></name>. <article-title>Proof-of-concept study of the efficacy of a microbiota-directed
complementary food formulation (MDCF) for treating moderate acute
malnutrition</article-title>. <source>BMC Public Health</source><volume>20</volume>, <fpage>242</fpage> (<year>2020</year>) <pub-id pub-id-type="pmid">32066412</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><name><surname>Ritchie</surname><given-names>M.E.</given-names></name>, <name><surname>Phipson</surname><given-names>B.</given-names></name>, <name><surname>Wu</surname><given-names>D.</given-names></name>, <name><surname>Hu</surname><given-names>Y.</given-names></name>, <name><surname>Law</surname><given-names>C.W.</given-names></name>, <name><surname>Shi</surname><given-names>W.</given-names></name>, <name><surname>Smyth</surname><given-names>G.K.</given-names></name>. <article-title>limma powers differential expression analyses for RNA-sequencing
and microarray studies</article-title>. <source>Nucleic Acids Research</source><volume>43</volume><fpage>e47</fpage> (<year>2015</year>) <pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><name><surname>Sergushichev</surname><given-names>A.</given-names></name>. <article-title>An algorithm for fast preranked gene set enrichment analysis using
cumulative statistic calculation</article-title>. <source>bioRxiv</source>
(<year>2016</year>). </mixed-citation>
              </ref>
              <ref id="R14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><name><surname>Gold</surname><given-names>L.</given-names></name>, <name><surname>Ayers</surname><given-names>L.,D.</given-names></name>, <name><surname>Bertino</surname><given-names>J.</given-names></name>, <name><surname>Bock</surname><given-names>C.</given-names></name>, <name><surname>Bock</surname><given-names>A.</given-names></name>, <name><surname>Brody</surname><given-names>E.N.</given-names></name>, <name><surname>Carter</surname><given-names>J.</given-names></name>, <name><surname>Dalby</surname><given-names>A.B.</given-names></name>, <name><surname>Eaton</surname><given-names>B.E.</given-names></name>, <name><surname>Fitzwater</surname><given-names>T.</given-names></name>, <name><surname>Flather</surname><given-names>D.</given-names></name>, <name><surname>Forbes</surname><given-names>A.</given-names></name>, <name><surname>Foreman</surname><given-names>T.</given-names></name>, <name><surname>Fowler</surname><given-names>C.</given-names></name>, <name><surname>Gawande</surname><given-names>B.</given-names></name>, <name><surname>Goss</surname><given-names>M.</given-names></name>, <name><surname>Gunn</surname><given-names>M.</given-names></name>, <name><surname>Gupta</surname><given-names>S.</given-names></name>, <name><surname>Halladay</surname><given-names>D.</given-names></name>, <name><surname>Heil</surname><given-names>J.</given-names></name>, <name><surname>Heilig</surname><given-names>J.</given-names></name>, <name><surname>Hicke</surname><given-names>B.</given-names></name>, <name><surname>Husar</surname><given-names>G.</given-names></name>, <name><surname>Janjic</surname><given-names>N.</given-names></name>, <name><surname>Harvis</surname><given-names>T.</given-names></name>, <name><surname>Jennings</surname><given-names>S.</given-names></name>, <name><surname>Katilius</surname><given-names>E.</given-names></name>, <name><surname>Kenney</surname><given-names>T.R.</given-names></name>, <name><surname>Kim</surname><given-names>N.</given-names></name>. <name><surname>Koch</surname><given-names>T.H.</given-names></name>, <name><surname>Kraemer</surname><given-names>S.</given-names></name>, <name><surname>Kroiss</surname><given-names>L.</given-names></name>, <name><surname>Le</surname><given-names>N.</given-names></name>, <name><surname>Levine</surname><given-names>D.</given-names></name>, <name><surname>Lindsey</surname><given-names>W.</given-names></name>, <name><surname>Lollo</surname><given-names>B.</given-names></name>, <name><surname>Mayfield</surname><given-names>W.</given-names></name>, <name><surname>Mehan</surname><given-names>M.</given-names></name>, <name><surname>Mehler</surname><given-names>R.</given-names></name>, <name><surname>Nelson</surname><given-names>S.K.</given-names></name>, <name><surname>Nelson</surname><given-names>M.</given-names></name>, <name><surname>Nieuwlandt</surname><given-names>D.</given-names></name>, <name><surname>Nikrad</surname><given-names>M.</given-names></name>, <name><surname>Ochsner</surname><given-names>U.</given-names></name>, <name><surname>Ostroff</surname><given-names>R.M.</given-names></name>, <name><surname>Otis</surname><given-names>M.</given-names></name>, <name><surname>Parker</surname><given-names>T.</given-names></name>, <name><surname>Pietrasiewicz</surname><given-names>S.</given-names></name>, <name><surname>Resnicow</surname><given-names>D.L.</given-names></name>, <name><surname>Rohloff</surname><given-names>J.</given-names></name>, <name><surname>Sanders</surname><given-names>G.</given-names></name>, <name><surname>Sattin</surname><given-names>S.</given-names></name>, <name><surname>Schneider</surname><given-names>D.</given-names></name>, <name><surname>Singer</surname><given-names>B.</given-names></name>, <name><surname>Stanton</surname><given-names>M.</given-names></name>, <name><surname>Sterkel</surname><given-names>A.</given-names></name>, <name><surname>Stewart</surname><given-names>A.</given-names></name>, <name><surname>Stratford</surname><given-names>S.</given-names></name>, <name><surname>Vaught</surname><given-names>J.D.</given-names></name>, <name><surname>Vrkljan</surname><given-names>M.</given-names></name>, <name><surname>Walker</surname><given-names>J.J.</given-names></name>, <name><surname>Watrobka</surname><given-names>M.</given-names></name>, <name><surname>Waugh</surname><given-names>S.</given-names></name>, <name><surname>Weiss</surname><given-names>A.</given-names></name>, <name><surname>Wilcox</surname><given-names>S.</given-names></name>, <name><surname>Wolfson</surname><given-names>A.</given-names></name>, <name><surname>Wolk</surname><given-names>S.</given-names></name>, <name><surname>Zhang</surname><given-names>C.</given-names></name>, <name><surname>Zichi</surname><given-names>D.</given-names></name>. <article-title>Aptamer-based multiplexed proteomic technology for biomarker
discovery</article-title>. <source>PLoS One</source><volume>5</volume> (<year>2010</year>). </mixed-citation>
              </ref>
              <ref id="R15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><name><surname>Burger</surname><given-names>A.</given-names></name>, <name><surname>Roosenboom</surname><given-names>J.</given-names></name>, <name><surname>Hossain</surname><given-names>M.</given-names></name>, <name><surname>Weinberg</surname><given-names>S.M.</given-names></name>, <name><surname>Hecht</surname><given-names>J.T.</given-names></name>, <name><surname>Posey</surname><given-names>K.L.</given-names></name>. <article-title>Mutant COMP shapes growth and development of skull and facial
structures in mice and humans</article-title>. <source>Mol. Genet. Genomic Med.</source><fpage>1</fpage>–<lpage>8</lpage> (<year>2020</year>). </mixed-citation>
              </ref>
              <ref id="R16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><name><surname>Bjarnason</surname><given-names>R.</given-names></name>, <name><surname>Andersson</surname><given-names>B.</given-names></name>, <name><surname>Kim</surname><given-names>H.S.</given-names></name>, <name><surname>Olsson</surname><given-names>B.</given-names></name>, <name><surname>Swolin-Eide</surname><given-names>D.</given-names></name>, <name><surname>Wickelgren</surname><given-names>R.</given-names></name>, <name><surname>Kriström</surname><given-names>B.</given-names></name>, <name><surname>Carlsson</surname><given-names>B.</given-names></name>, <name><surname>Albertsson-Wikland</surname><given-names>K.</given-names></name>, <name><surname>Carlsson</surname><given-names>L.M.S.</given-names></name>. <article-title>Cartilage oligomeric matrix protein increases in serum after the
start of growth hormone treatment in prepubertal children</article-title>. <source>J.
Clin. Endocr. Metab.</source><volume>89</volume>, <fpage>5156</fpage>–<lpage>5160</lpage> (<year>2004</year>).
<pub-id pub-id-type="pmid">15472220</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>K.</given-names></name>, <name><surname>Ng</surname><given-names>P.Y.</given-names></name>, <name><surname>Chen</surname><given-names>R.</given-names></name>, <name><surname>Hu</surname><given-names>D.</given-names></name>, <name><surname>Berry</surname><given-names>S.</given-names></name>, <name><surname>Baron</surname><given-names>R.</given-names></name>, <name><surname>Gori</surname><given-names>F.</given-names></name>, <article-title>Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects
cortical bone from excessive endosteal resorption</article-title>. <source>Proc.. Natl.
Acad.Sci. U.S.A.</source><volume>116</volume>, <fpage>14138</fpage>–<lpage>14143</lpage>
(<year>2019</year>). <pub-id pub-id-type="pmid">31239337</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>H.</given-names></name>, <name><surname>Choi</surname><given-names>Y.J.</given-names></name>, <name><surname>Lee</surname><given-names>Y.S.</given-names></name>, <name><surname>Park</surname><given-names>S.Y.</given-names></name>, <name><surname>Baek</surname><given-names>J.E.</given-names></name>, <name><surname>Kim</surname><given-names>H.K.</given-names></name>, <name><surname>Kim</surname><given-names>B.J.</given-names></name>, <name><surname>Lee</surname><given-names>S.H.</given-names></name>, <name><surname>Koh</surname><given-names>J.M.</given-names></name>. <article-title>SLIT3 regulates endochondral ossification by β-catenin
suppression in chondrocytes</article-title>. <source>Biochem. Biophys. Res.
Comm.</source><volume>506</volume>, <fpage>847</fpage>–<lpage>853</lpage> (<year>2018</year>).
<pub-id pub-id-type="pmid">30389141</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><name><surname>Diamond</surname><given-names>M.S.</given-names></name>, <name><surname>Farzan</surname><given-names>M.</given-names></name>. <article-title>The broad-spectrum antiviral functions of IFIT and IFITM
proteins</article-title>. <source>Nature Rev. Immunol.</source><volume>13</volume>, <fpage>46</fpage>–<lpage>57</lpage> (<year>2013</year>).
<pub-id pub-id-type="pmid">23237964</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><name><surname>Bernardo</surname><given-names>B.C.</given-names></name>, <name><surname>Belluoccio</surname><given-names>D.</given-names></name>, <name><surname>Rowley</surname><given-names>L.</given-names></name>, <name><surname>Little</surname><given-names>C.B.</given-names></name>, <name><surname>Hansen</surname><given-names>U</given-names></name>, <name><surname>Bateman</surname><given-names>J.F.</given-names></name>. <article-title>Cartilage intermediate layer protein 2 (CILP-2) is expressed in
articular and meniscal cartilage and down-regulated in experimental
osteoarthritis</article-title>. <source>J.Biol. Chem.</source><volume>286</volume>, <fpage>37758</fpage>–<lpage>37767</lpage>
(<year>2011</year>). <pub-id pub-id-type="pmid">21880736</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><name><surname>Stenina-adognravi</surname><given-names>O.</given-names></name>, <name><surname>Plow</surname><given-names>E.F.</given-names></name>. <article-title>Thrombospondin-4 in tissue remodeling</article-title>.
<source>Matrix Biol</source>. <volume>75–76</volume>,
<fpage>300</fpage>–<lpage>313</lpage> (<year>2019</year>). </mixed-citation>
              </ref>
              <ref id="R22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><name><surname>Sawaya</surname><given-names>A.L.</given-names></name>, <name><surname>Martins</surname><given-names>P.</given-names></name>, <name><surname>Hoffman</surname><given-names>D.</given-names></name>, <name><surname>Roberts</surname><given-names>S.B.</given-names></name>. <article-title>The Link Between Childhood Undernutrition and Risk of Chronic
Diseases in Adulthood : A Case Study of Brazil</article-title>. <source>Nutr.
Rev.</source><volume>61</volume>, <fpage>168</fpage>–<lpage>175</lpage> (<year>2003</year>).
<pub-id pub-id-type="pmid">12822705</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><name><surname>Popkin</surname><given-names>B.M.</given-names></name>, <name><surname>Corvalan</surname><given-names>C.</given-names></name>, <name><surname>Grummer-Strawn</surname><given-names>L.M.</given-names></name>, <article-title>Dynamics of the double burden of malnutrition and the changing
nutrition reality</article-title>. <source>Lancet</source><volume>395</volume>, <fpage>65</fpage>‐<lpage>74</lpage> (<year>2020</year>).
<pub-id pub-id-type="pmid">31852602</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>T.</given-names></name>, <name><surname>Zhang</surname><given-names>Q.</given-names></name>, <name><surname>Wu</surname><given-names>S.</given-names></name>, <name><surname>Hu</surname><given-names>W.</given-names></name>, <name><surname>Zhou</surname><given-names>T.</given-names></name>, <name><surname>Li</surname><given-names>K.</given-names></name>, <name><surname>Liu</surname><given-names>D.</given-names></name>. <article-title>CILP- 2 is a novel secreted protein and associated with insulin
resistance</article-title>. <source>J. Mol. Cell. Biol.</source><volume>11</volume>, <fpage>1083</fpage>–<lpage>1094</lpage> (<year>2019</year>).
<pub-id pub-id-type="pmid">30896018</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><name><surname>Willer</surname><given-names>C.J.</given-names></name>, <name><surname>Sanna</surname><given-names>S.</given-names></name>, <name><surname>Jackson</surname><given-names>A.U.</given-names></name>, <name><surname>Scuteri</surname><given-names>A.</given-names></name>, <name><surname>Bonnycastle</surname><given-names>L.L.</given-names></name>, <name><surname>Clarke</surname><given-names>R.</given-names></name>, <name><surname>Heath</surname><given-names>S.C.</given-names></name>, <name><surname>Timpson</surname><given-names>N.J.</given-names></name>, <name><surname>Najjar</surname><given-names>S.S.</given-names></name>, <name><surname>Stringham</surname><given-names>H.M.</given-names></name>, <name><surname>Strait</surname><given-names>J.</given-names></name>, <name><surname>Duren</surname><given-names>W.L.</given-names></name>, <name><surname>Maschio</surname><given-names>A.</given-names></name>, <name><surname>Busonero</surname><given-names>F.</given-names></name>, <name><surname>Mulas</surname><given-names>A.</given-names></name>, <name><surname>Albai</surname><given-names>G.</given-names></name>, <name><surname>Swift</surname><given-names>A.J.</given-names></name>, <name><surname>Morken</surname><given-names>M.A.</given-names></name>, <name><surname>Narisu</surname><given-names>N.</given-names></name>, <name><surname>Mohlke</surname><given-names>K.L.</given-names></name>. <article-title>Newly identified loci that influence lipid concentrations and risk
of coronary artery disease</article-title>. <source>Nature Genet</source>.
<volume>40</volume>, <fpage>161</fpage>–<lpage>169</lpage> (<year>2008</year>).
<pub-id pub-id-type="pmid">18193043</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><name><surname>Saxena</surname><given-names>R.</given-names></name>, <name><surname>Elbers</surname><given-names>C.C.</given-names></name>, <name><surname>Guo</surname><given-names>Y.</given-names></name>, <name><surname>Peter</surname><given-names>I.</given-names></name>,<name><surname>Gaunt</surname><given-names>T.R.</given-names></name>, <name><surname>Mega</surname><given-names>J.L.</given-names></name>, <name><surname>Lanktree</surname><given-names>M.B.</given-names></name>, <name><surname>Tare</surname><given-names>A.</given-names></name>, <name><surname>Castillo</surname><given-names>B.A.</given-names></name>, <name><surname>Li</surname><given-names>Y.R.</given-names></name>, <name><surname>Johnson</surname><given-names>T.</given-names></name>, <name><surname>Bruinenberg</surname><given-names>M.</given-names></name>, <name><surname>Gilbert-Diamond</surname><given-names>D.</given-names></name>, <name><surname>Rajagopalan</surname><given-names>R.</given-names></name>, <name><surname>Voight</surname><given-names>B.F.</given-names></name>, <name><surname>Balasubramanyan</surname><given-names>A.</given-names></name>, <name><surname>Barnard</surname><given-names>J.</given-names></name>, <name><surname>Braund</surname><given-names>P.S.</given-names></name>, <name><surname>Bauer</surname><given-names>F.</given-names></name>, <name><surname>Vliet-ostaptchouk</surname><given-names>J.V. Van</given-names></name>. <article-title>Large-Scale Gene-Centric Meta-Analysis across 39 Studies
Identifies Type 2 Diabetes Loci</article-title>. <source>Am. J. Hum. Genet.</source><fpage>410</fpage>–<lpage>425</lpage> (<year>2012</year>). <pub-id pub-id-type="pmid">22325160</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><name><surname>Rzehak</surname><given-names>P.</given-names></name>, <name><surname>Covic</surname><given-names>M.</given-names></name>, <name><surname>Saffery</surname><given-names>R.</given-names></name>, <name><surname>Reischl</surname><given-names>E.</given-names></name>, <name><surname>Wahl</surname><given-names>S.</given-names></name>, <name><surname>Grote</surname><given-names>V.</given-names></name>, <name><surname>Weber</surname><given-names>M.</given-names></name>, <name><surname>Xhonneux</surname><given-names>A.</given-names></name>, <name><surname>Langhendries</surname><given-names>J.</given-names></name>, <name><surname>Ferre</surname><given-names>N.</given-names></name>, <name><surname>Escribano</surname><given-names>J.</given-names></name>, <name><surname>Verduci</surname><given-names>E.</given-names></name>, <name><surname>Riva</surname><given-names>E.</given-names></name>, <name><surname>Socha</surname><given-names>P.</given-names></name>, <article-title>DNA-Methylation and Body Composition in Preschool
Children : Epigenome-Wide-Analysis in the European Childhood Obesity Project
(CHOP) Study</article-title>. <source>Sci. Rep.</source><fpage>1</fpage>–<lpage>13</lpage> (<year>2017</year>). <pub-id pub-id-type="pmid">28127051</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><name><surname>Brix</surname><given-names>J.M.</given-names></name>, <name><surname>Krzizek</surname><given-names>E.C.</given-names></name>, <name><surname>Hoebaus</surname><given-names>C.</given-names></name>, <name><surname>Ludvik</surname><given-names>B.</given-names></name>, <name><surname>Schernthaner</surname><given-names>G.</given-names></name>, <name><surname>Schernthaner</surname><given-names>G.H.</given-names></name>. <article-title>Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in
Patients with Diabetes Mellitus</article-title>. <source>Horm. Metab. Res.</source><volume>48</volume>, <fpage>345</fpage>–<lpage>348</lpage> (<year>2016</year>).
<pub-id pub-id-type="pmid">26882051</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <label>29.</label>
                <mixed-citation publication-type="journal"><name><surname>Hoffmann</surname><given-names>M.M.</given-names></name>, <name><surname>Werner</surname><given-names>C.</given-names></name>, <name><surname>Böhm</surname><given-names>M.</given-names></name>, <name><surname>Laufs</surname><given-names>U.</given-names></name>, <name><surname>Winkler</surname><given-names>K.</given-names></name>. <article-title>Association of secreted frizzled-related protein 4 (SFRP4) with
type 2 diabetes in patients with stable coronary artery disease</article-title>.
<source>Cardio. Diabetol.</source><volume>13</volume>, <fpage>1</fpage>–<lpage>8</lpage> (<year>2014</year>).
</mixed-citation>
              </ref>
              <ref id="R30">
                <label>30.</label>
                <mixed-citation publication-type="journal"><name><surname>Zierfuss</surname><given-names>B.</given-names></name>, <name><surname>Hobaus</surname><given-names>C.</given-names></name>, <name><surname>Hertz</surname><given-names>C.T.</given-names></name>, <name><surname>Pesau</surname><given-names>G.</given-names></name>, <name><surname>Koppensteiner</surname><given-names>R.</given-names></name>, <name><surname>Schernthaner</surname><given-names>G-H.</given-names></name>. <article-title>Thrombospondin-4 indcreases with the severity of peripheral
arterial disease and is associated with diabetes</article-title>. <source>Heart and
Vessels</source>. <volume>35</volume>, <fpage>52</fpage>–<lpage>58</lpage>
(<year>2020</year>) <pub-id pub-id-type="pmid">31227875</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <label>31.</label>
                <mixed-citation publication-type="journal"><name><surname>Conlisk</surname><given-names>A.J.</given-names></name>, <name><surname>Barnhart</surname><given-names>H.X.</given-names></name>, <name><surname>Martorell</surname><given-names>R.</given-names></name>, <name><surname>Grajeda</surname><given-names>R.</given-names></name>, <name><surname>Stein</surname><given-names>A.D.</given-names></name>. <article-title>Maternal and Child Nutritional Supplementation Are Inversely
Associated with Fasting Plasma Glucose Concentration in Young Guatemalan
Adults</article-title>. <source>J. Nutr.</source><volume>134</volume>, <fpage>890</fpage>–<lpage>897</lpage> (<year>2004</year>).
<pub-id pub-id-type="pmid">15051843</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <label>32.</label>
                <mixed-citation publication-type="journal"><name><surname>Kinra</surname><given-names>S.</given-names></name>, <name><surname>Rameshwar Sarma</surname><given-names>K.V.</given-names></name>, <name><surname>Ghafoorunissa</surname><given-names>V. V.</given-names></name><name><surname>Mendu</surname><given-names>R.</given-names></name>, <name><surname>Ravikumar</surname><given-names>R.</given-names></name>, <name><surname>Mohan</surname><given-names>V.</given-names></name>, <name><surname>Wilkinson</surname><given-names>I.B.</given-names></name>, <name><surname>Cockcroft</surname><given-names>J.R.</given-names><suffix>J. R.</suffix></name>, <name><surname>Smith</surname><given-names>G.D.</given-names></name>. <name><surname>Ben-Shlomo</surname><given-names>Y.</given-names></name>, <article-title>Effect of integration of supplemental nutrition with public health
programmes in pregnancy and early childhood on cardiovascular risk in rural Indian
adolescents: Long term follow-up of Hyderabad nutrition trial</article-title>.
<source>BMJ</source>. <volume>337</volume>, <fpage>445</fpage>–<lpage>449</lpage>
(<year>2008</year>). </mixed-citation>
              </ref>
              <ref id="R33">
                <label>33.</label>
                <mixed-citation publication-type="journal"><name><surname>Abera</surname><given-names>M.</given-names></name>, <name><surname>Tesfaye</surname><given-names>M.</given-names></name>, <name><surname>Admassu</surname><given-names>B.</given-names></name>, <name><surname>Hanlon</surname><given-names>C.</given-names></name>, <name><surname>Ritz</surname><given-names>C.</given-names></name>, <name><surname>Wibaek</surname><given-names>R.</given-names></name>, <name><surname>Michaelsen</surname><given-names>K.F.</given-names></name>, <name><surname>Friis</surname><given-names>H.</given-names></name>, <name><surname>Wells</surname><given-names>J.C.</given-names></name>, <name><surname>Andersen</surname><given-names>G.S.</given-names></name>, <name><surname>Girma</surname><given-names>R.</given-names></name>, <name><surname>Kaestel</surname><given-names>P.</given-names></name>. <article-title>Body composition during early infancy and developmental
progression from 1 to 5 years of age: The Infant Anthropometry and Body Composition
(iABC) cohort study among Ethiopian children</article-title>. <source>Br. J.
Nutr.</source><volume>119</volume>,<fpage>1263</fpage>–<lpage>1273</lpage> (<year>2018</year>).
<pub-id pub-id-type="pmid">29770755</pub-id></mixed-citation>
              </ref>
              <ref id="R34">
                <label>34.</label>
                <mixed-citation publication-type="journal"><name><surname>Olsen</surname><given-names>M.F.</given-names></name>, <name><surname>Iuel-Brockdorff</surname><given-names>A.S.</given-names></name>, <name><surname>Yaméogo</surname><given-names>C.W.</given-names></name>, <name><surname>Cichon</surname><given-names>B.</given-names></name>, <name><surname>Fabiansen</surname><given-names>C.</given-names></name>, <name><surname>Filteau</surname><given-names>S.</given-names></name>, <name><surname>Phelan</surname><given-names>K.</given-names></name>, <name><surname>Ouédraogo</surname><given-names>A.</given-names></name>, <name><surname>Wells</surname><given-names>J.C.</given-names></name>, <name><surname>Briend</surname><given-names>A.</given-names></name>, <name><surname>Michaelsen</surname><given-names>K.F.</given-names></name>, <name><surname>Lauritzen</surname><given-names>L.</given-names></name>, <name><surname>Ritz</surname><given-names>C.</given-names></name>, <name><surname>Ashorn</surname><given-names>P.</given-names></name>, <name><surname>Christensen</surname><given-names>V.B.</given-names></name>, <name><surname>Gladstone</surname><given-names>M.</given-names></name>, <name><surname>Friss</surname><given-names>H.</given-names></name>. <article-title>Early development in children with moderate acute malnutrition: A
cross-sectional study in Burkina Faso</article-title>. <source>Mat. Child Nutr.</source><volume>16</volume>, <fpage>1</fpage>–<lpage>14</lpage> (<year>2020</year>).
</mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="F1" orientation="portrait" position="float">
              <label>Fig. 1:</label>
              <caption>
                <title>Study design of a randomized controlled trial of MDCF-2 or RUSF supplementation in
children with MAM.</title>
                <p id="P35"><bold>(A)</bold> Study design. <bold>(B)</bold> WLZ during treatment. Best-fit linear
regression lines are colored green (MDCF-2) or red (RUSF), and the lighter shaded areas
around the lines indicate 95% confidence bands. The β-coefficient of +0.011
represents the weekly change in WLZ in children receiving MDCF-2 compared to those
receiving RUSF. The 95% confidence interval is shown in parentheses. </p>
              </caption>
              <graphic xlink:href="nihms-1681256-f0001"/>
            </fig>
            <fig id="F2" orientation="portrait" position="float">
              <label>Fig. 2:</label>
              <caption>
                <title>Effects of Nutritional Intervention on Plasma Proteins.</title>
                <p id="P36"><bold>(A-C)</bold> Schematic depicting the calculation of ‘β-WLZ’ for
each participant (panel A), ‘Δprotein abundance’ for each participant
(panel B) and the correlation between these two values (panel C). <bold>(D)</bold> Gene
set enrichment analysis (GSEA) of proteins whose abundances were correlated with ponderal
growth. The vertical gray line indicates q&lt;0.05. <bold>(E-H)</bold> Gene Ontology
(GO) terms enriched for by the set of WLZ-associated proteins. Shown are the correlation
strengths between proteins belonging to a GO term and ponderal growth. Only proteins whose
correlations with β-WLZ reached an unadjusted p&lt;0.01 are shown. Proteins are
ordered by correlation strength and colored by their p-value (transformed to a
−log<sub>10</sub> scale so that decreasing values indicate less statistical
significance). <bold>(I)</bold> Differential effects of MDCF-2 and RUSF on WLZ-associated
proteins. Proteins are ordered by the log<sub>2</sub>(fold-change) of the treatment effect
of MDCF-2 over RUSF after three months of supplementation. GSEA was used to calculate the
enrichment of proteins whose abundances were increased more by MDCF-2 compared to RUSF for
the set of 70 proteins that are positively correlated with β-WLZ. </p>
              </caption>
              <graphic xlink:href="nihms-1681256-f0002"/>
            </fig>
            <fig id="F3" orientation="portrait" position="float">
              <label>Fig. 3:</label>
              <caption>
                <title>Response of the Gut Microbiota to MDCF-2 and RUSF Supplementation.</title>
                <p id="P37"><bold>(A)</bold> Analytical scheme for linear mixed effects modeling of the relationship
between WLZ and taxon (ASV) abundance during supplementation. The coefficient
β<sub>1</sub> represents the change in WLZ for a unit change in the
variance-stabilizing, transformed abundance of an ASV. A random effect for participant ID
(PID) was included in the model to account for repeated measurements taken from the same
individual. Bar graphs indicate β<sub>1</sub> (the linear model coefficients)
± SEM for each taxon that was significantly associated with WLZ. ASVs in bold-face
were previously identified as ‘ecogroup’ taxa(<xref rid="R5" ref-type="bibr">5</xref>), while those with asterisks have previously described associations with
weight gain in gnotobiotic mice harboring gut microbial communities obtained from healthy
and undernourished children(<xref rid="R10" ref-type="bibr">10</xref>). <bold>(B)</bold>
Ratio of 3-month Δ<sub>ASV</sub> (the change in variance-stabilizing transformed
ASV counts prior to and after supplementation) between MDCF-2 and RUSF treatment arms. A
positive ratio indicates a greater average increase in children treated with MDCF-2. Color
scheme: red bars, ASVs with significant positive associations with WLZ; blue bars, ASVs
with significant negative associations with WLZ. </p>
              </caption>
              <graphic xlink:href="nihms-1681256-f0003"/>
            </fig>
            <table-wrap id="T1" orientation="portrait" position="float">
              <label>Table 1:</label>
              <caption>
                <p id="P38">Clinical characteristics at enrollment</p>
              </caption>
              <table frame="box" rules="all">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="center" valign="middle" rowspan="1" colspan="1"/>
                    <th align="center" valign="middle" rowspan="1" colspan="1">MDCF-2 (n=61)</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">RUSF (n=62)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>Demographic Features</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Age (months)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">15.4 ± 1.9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">15.5 ± 2.0</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Female - no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">35 (57%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">36 (58%)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>Anthropometry at enrollment</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WLZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.31 ± 0.29</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.40 ± 0.27</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.69 ± 0.67</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.76 ± 0.62</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">LAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.08 ± 1.16</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.08 ± 1.12</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MUAC (cm)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">12.8 ± 0.53</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">12.7 ± 0.44</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>Breastfeeding status†</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Not breastfed since birth - no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (2%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0 (0%)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Partial breastfeeding - no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">46 (75%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">46 (74%)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Exclusive breastfeeding - no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">14 (23%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">16 (26%)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>Immunization status</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                    <td align="center" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Complete - no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">53 (87%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">52 (84%)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Partial - no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8 (13%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6 (10%)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">None - no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0 (0%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4 (6%)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <p id="P39">WLZ: weight-for-length z-score. WAZ: weight-for-age z-score. LAZ:
length-for-age z-score. MUAC: mid-upper arm circumference.</p>
                </fn>
                <fn id="TFN2">
                  <p id="P40">Values represent: mean ± SD; number (%); median [interquartile
range].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="T2" orientation="portrait" position="float">
              <label>Table 2:</label>
              <caption>
                <p id="P41">Clinical response to MDCF-2 or RUSF supplementation</p>
              </caption>
              <table frame="box" rules="all">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <tbody>
                  <tr>
                    <th colspan="4" align="center" valign="middle" rowspan="1">Anthropometry at the start of
intervention i.e. baseline</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" rowspan="1" colspan="1"/>
                    <th align="center" valign="middle" rowspan="1" colspan="1">MDCF-2 (n=59)<xref rid="TFN3" ref-type="table-fn">†</xref></th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">RUSF (n=59)<xref rid="TFN3" ref-type="table-fn">†</xref></th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">β Treatment (95% CI)<xref rid="TFN4" ref-type="table-fn">‡</xref></th>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WLZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.22 ± 0.39</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.29 ± 0.36</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.086 (−0.056, 0.228)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.66 ± 0.67</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.71 ± 0.64</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.036 (−0.213, 0.285)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">LAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.14 ± 1.14</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−2.13 ± 1.13</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.044 (−0.467, 0.380)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MUAC (cm)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">12.8 ± 0.51</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">12.7 ± 0.44</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.077 (−0.100, 0.254)</td>
                  </tr>
                </tbody>
                <tbody>
                  <tr>
                    <th colspan="4" align="center" valign="middle" rowspan="1">Rate of growth during intervention
(Δ anthropometry/week)</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" rowspan="1" colspan="1"/>
                    <th align="center" valign="middle" rowspan="1" colspan="1">β growth rate for MDCF-2 (95% CI)<xref rid="TFN5" ref-type="table-fn">§</xref></th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">β growth rate for RUSF (95% CI)<xref rid="TFN5" ref-type="table-fn">§</xref></th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">β Interaction (95% CI)<xref rid="TFN6" ref-type="table-fn">¤</xref></th>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WLZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.021 (0.014, 0.029)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.010 (0.003, 0.017)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011 (0.001, 0.021)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.017 (0.012, 0.022)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.010 (0.004, 0.015)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.008 (0.001, 0.015)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">LAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.004 (0.002, 0.007)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.005 (0.003, 0.008)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.001 (−0.005, 0.003)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MUAC (cm)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.031 (0.029, 0.034)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.029 (0.025, 0.032)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.003 (−0.001, 0.007)</td>
                  </tr>
                </tbody>
                <tbody>
                  <tr>
                    <th colspan="4" align="center" valign="middle" rowspan="1">Rate of growth including the 1-month
follow-up (Δ anthropometry/week)</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" rowspan="1" colspan="1"/>
                    <th align="center" valign="middle" rowspan="1" colspan="1">β growth rate for MDCF-2 (95% CI)<xref rid="TFN5" ref-type="table-fn">§</xref></th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">β growth rate for RUSF (95% CI)<xref rid="TFN5" ref-type="table-fn">§</xref></th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">β Interaction (95% CI)<xref rid="TFN6" ref-type="table-fn">¤</xref></th>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WLZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.010 (0.005, 0.016)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.000 (−0.005, 0.006)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.010 (0.002, 0.018)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.009 (0.005, 0.013)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.001 (−0.003, 0.005)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.008 (0.002, 0.013)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">LAZ</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.004 (0.002, 0.006)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.003 (0.001, 0.006)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.000 (−0.003, 0.003)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MUAC (cm)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.028 (0.026, 0.031)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.024 (0.022, 0.027)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.004 (0.000, 0.007)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN3">
                  <label>†</label>
                  <p id="P42">Values represent the mean ± SD.</p>
                </fn>
                <fn id="TFN4">
                  <label>‡</label>
                  <p id="P43">Linear model predicting anthropometry at the start of the intervention as a
function of treatment group, controlling for baseline age, gender and any illness 7 days
prior to starting the intervention. β indicates the mean difference in
anthropometry between participants who were assigned to the MDCF-2 and RUSF arms at the
start of the intervention. CI, confidence interval.</p>
                </fn>
                <fn id="TFN5">
                  <label>§</label>
                  <p id="P44">Mixed effects linear model predicting anthropometry as a function of weeks
since starting nutritional supplementation, controlling for the main effects of baseline
age, gender, any illness 7 days prior to starting the intervention, and a random
intercept for each participant. β indicates the growth rate in unit
(anthropometric measure) per week.</p>
                </fn>
                <fn id="TFN6">
                  <label>¤</label>
                  <p id="P45">Mixed effects linear model predicting anthropometry as a function of the
interaction between treatment group and weeks since starting nutritional
supplementation, controlling for the main effects of baseline age, gender, any illness 7
days prior to starting the intervention, weeks in the intervention, treatment group, and
a random intercept for each participant. β indicates the interaction between
treatment and growth rate in unit/week (a positive value indicates a faster growth rate
in children receiving MDCF-2).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
